Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of popular, augmented reality, interactive, entertainment games and toys in China, is well positioned in a market that is anticipated to see continuous growth in the coming years. A recent article discussing the company reads, “The global augmented reality (‘AR’) and virtual reality…
Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a biotechnology company and drug-delivery platform innovator, is increasing the reach of its revolutionary DehydraTECH(TM) technology that enables the rapid onset of ingested cannabis. An article discussing the company reads, “DehydraTECH is a drug-delivery technology that gets ingested active pharmaceutical ingredient (API) molecules to the bloodstream faster than other…
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, this morning announced that it has received final approval to list its common shares on the Toronto Stock Exchange (“TSX”). The company’s common shares will start trading on the TSX when the market opens on Thursday, August…
Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, this morning announced the entry of its wholly owned subsidiary, Khrysos Industries, Inc., into a 5-year supply contract with DJB Industries Inc. to provide extraction services and end-to-end processing to produce isolate, water soluble isolate, distillate, and water-soluble distillate hemp…
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of popular, augmented-reality, interactive, entertainment games and toys in China, recently entered a strategic agreement with Guangdong Family Periodicals Group. The two companies are partnering to develop innovative educational solutions that feature Blue Hat technologies (http://ibn.fm/TDA6M). A recent article discussing the company reads,…
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, this morning announced the completion of its first shipment to the Ontario Cannabis Store. The shipment marks TGODF’s official entrance into Canada’s recreational market and provides consumers access to the company’s flagship strain, Unite Organic. The Ontario-grown dried flower will…
TransCanna Holdings (CSE: TCAN) (FSE: TH8) this morning announced a new appointment to its board of directors. Ian Klassen joins the board and will additionally serve as chair of the company’s audit committee. Klassen brings nearly 30 years of experience in business management, public relations and government affairs to the company. His background includes serving…
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning announced the entry of its portfolio companies, James E. Wagner Cultivation Corporation (“JWC”) (TSXV: JWCA) (OTCQX: JWCAF) and TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF), into a purchase and supply agreement, demonstrating collaboration and synergy that is seen throughout the Canopy Rivers ecosystem. Under the agreement, JWC will…
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced financial results for the second quarter ended June 30, 2019, provided a business update, and offered guidance for the remainder of the fiscal year and for FY…
Biotechnology company and global drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced the granting of four of its pending patent applications via its wholly-owned subsidiary Poviva Corp. According to the update, the new patents cover delivery of cannabinoids such as THC and CBD, NSAIDs such as ibuprofen, nicotine, and vitamins. With…
Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, this morning reported financial results for the second quarter and six months ended June 30, 2019. Per the update, the company’s revenues for second quarter were $53.7 million compared to $44.3 million in the prior year, reflecting an increase of…
Biotechnology company and global drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced the appointment of Brian Quigley to its board of directors. Quigley most recently spent 16 years at Altria Group, seven of which were spent as president and CEO for U.S. Smokeless Tobacco and Nu-Mark, Altria’s innovation company, during the…
TransCanna Holdings (CSE: TCAN) (FSE: TH8) this morning announced its entry into a definitive purchase agreement for all of the outstanding equity interest in Tres Ojos Naturals LLC, doing business as SolDaze, a Santa Cruz, California-based limited liability company. Per the update, the transaction will absorb SolDaze’s branding asset package into the company’s expanding asset…
Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) on Tuesday released its financial and operational results for the three and six months ended June 30, 2019. In addition, TGODF management hosted a call to discuss the results at 9:00 AM ET on August 14, 2019, and a playback is…
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, on Tuesday announced that it will host a teleconference to discuss its second quarter 2019 financial results and to provide a business update. The teleconference is scheduled for…
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) on Tuesday announced its plans to report first quarter fiscal year 2020 financial results before markets open on Tuesday, August 27, 2019. According to the update, Canopy Rivers will host a conference call and audio webcast following release of its results. The company’s president and CEO Narbe Alexandrian and…
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, has developed a unique, proprietary nano-emulsification technology that is anticipated to deliver an initial onset of effects within 10 to 15 minutes for cannabis beverages (http://ibn.fm/zy5Pt). A recent article discussing the company reads, “Organigram focuses on high-quality,…
Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced its recent achievements as part of the company’s overall strategy to expand its clinical development programs and bring its lead drug candidate, Oncoprex(TM) immunogene therapy, to commercialization. Per the update, Genprex has published recent as well as historical achievements to its newly launched, interactive corporate…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) today announced that Health Canada has issued cannabis Research and Development (“R&D”) license LIC-7NONT76UNW-2019 to its subsidiary, Lexaria CanPharm ULC. According to the update, the license, which carries a four-year term unless renewed, is effective immediately and will allow one of…
INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced its financial results for the second quarter ended June 30, 2019 and also provided a year-to-date business update. “This year we remained focused on advancing our pipeline,” INmune Bio CEO RJ…